Update: 28.09.2022
Last week: 37 week 2022 (12.09.2022 - 18.09.2022)
Last full month: Aug 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 190 168 | 31.8% | 3.8% | 0.1 | 38 811 488 | 33.7% | 3.8% | 0.1 | 29.1% |
| MoM | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| YTD | 7 330 740 | -1.2% | 5.6% | -0.4 | 1 450 450 116 | 16.2% | 5.4% | 0 | 6.1% |
| MAT | 13 176 846 | 20.9% | 6.1% | 0.7 | 2 492 840 586 | 40.5% | 5.7% | 0.9 | 6.5% |
| DEXALGIN | |||||||||
| WoW | 19 805 | 9.3% | 0.3% | 0 | 9 424 692 | 10.5% | 1.0% | 0 | 9.4% |
| MoM | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| YTD | 1 297 619 | 9.6% | 0.7% | 0 | 545 098 982 | 21.2% | 1.9% | 0.1 | 2.7% |
| MAT | 1 952 122 | 7.4% | 0.7% | 0 | 796 157 267 | 16.9% | 2.0% | 0.1 | 1.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 67 004 | 2.5% | 47.3% | -0.8 | 35 390 881 | 3.4% | 53.1% | -0.6 | 4.3% |
| MoM | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| YTD | 3 439 361 | -5.6% | 56.7% | -9.9 | 1 744 537 294 | 5.8% | 62.2% | -8.3 | 10.9% |
| MAT | 5 077 839 | -0.4% | 59.0% | -7.2 | 2 520 709 494 | 12.1% | 64.4% | -5.8 | 11.8% |
| ESPUMISAN BABY | |||||||||
| WoW | 25 912 | 2.8% | 33.1% | -0.3 | 16 886 702 | 2.6% | 46.8% | -0.2 | 3.6% |
| MoM | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| YTD | 1 070 072 | -10.3% | 38.1% | -3.9 | 664 714 290 | -4.1% | 51.4% | -5.4 | -1.1% |
| MAT | 1 540 677 | -11.3% | 38.6% | -3 | 943 325 956 | -3.8% | 52.3% | -3.5 | -4.4% |
| FASTUM | |||||||||
| WoW | 16 503 | 3.5% | 0.8% | 0 | 9 107 843 | 3.8% | 2.0% | -0.1 | 9.0% |
| MoM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| YTD | 797 893 | -20.1% | 1.2% | -0.3 | 409 730 966 | -10.6% | 2.6% | -0.6 | 1.2% |
| MAT | 1 184 261 | -18.5% | 1.2% | -0.3 | 591 585 623 | -9.8% | 2.7% | -0.5 | 0.5% |
| IODOMARIN | |||||||||
| WoW | 69 109 | 3.3% | 23.2% | -0.2 | 12 806 239 | 1.8% | 9.7% | -0.3 | 4.3% |
| MoM | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| YTD | 2 171 109 | 5.3% | 19.3% | 0 | 432 985 546 | 11.6% | 8.7% | 0 | 5.4% |
| MAT | 3 275 591 | 24.4% | 20.5% | 2.9 | 637 437 162 | 26.1% | 9.3% | 1.1 | 6.8% |
| LIOTON | |||||||||
| WoW | 19 368 | 0.3% | 1.8% | -0.2 | 20 853 357 | 0.3% | 3.8% | -0.3 | 9.4% |
| MoM | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| YTD | 1 007 313 | -21.4% | 2.4% | -0.4 | 1 028 521 820 | -1.4% | 4.8% | -0.8 | -6.7% |
| MAT | 1 417 346 | -18.1% | 2.4% | -0.3 | 1 388 547 407 | 0.6% | 5.0% | -0.6 | -6.6% |
| MEZYM | |||||||||
| WoW | 245 436 | 7.7% | 19.1% | -0.4 | 37 700 689 | 7.5% | 13.8% | -0.1 | 9.9% |
| MoM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| YTD | 13 993 869 | 3.0% | 27.8% | 0.2 | 2 141 614 973 | 12.4% | 20.0% | -0.7 | 2.2% |
| MAT | 21 168 760 | 9.9% | 29.2% | 1.5 | 3 144 749 667 | 16.8% | 21.1% | 0.2 | 4.4% |
| MIG 400 | |||||||||
| WoW | 169 028 | 9.1% | 2.8% | 0 | 20 075 625 | 8.9% | 2.2% | 0 | 9.4% |
| MoM | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| YTD | 6 286 981 | -9.4% | 3.4% | -0.5 | 738 755 149 | -5.5% | 2.6% | -0.5 | 2.7% |
| MAT | 9 238 664 | -2.2% | 3.5% | -0.1 | 1 073 924 250 | 1.8% | 2.7% | -0.2 | 1.6% |
| PROSTAMOL | |||||||||
| WoW | 25 669 | 8.4% | 15.2% | -0.2 | 35 414 061 | 8.1% | 16.3% | 0.1 | 9.9% |
| MoM | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| YTD | 1 187 338 | -21.3% | 19.7% | -5.5 | 1 665 731 907 | -11.8% | 21.0% | -6.5 | 0.5% |
| MAT | 1 817 866 | -14.8% | 20.8% | -3.8 | 2 477 952 691 | -6.5% | 22.2% | -4.8 | 0.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 27 274 | 31.9% | 7.3% | -0.3 | 13 112 470 | 32.4% | 7.6% | -0.3 | 38.2% |
| MoM | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
| YTD | 877 042 | 165.4% | 9.0% | 5.4 | 409 537 409 | 159.3% | 8.8% | 4.7 | 6.5% |
| MAT | 1 293 371 | 130.8% | 8.5% | 4.5 | 596 485 558 | 121.1% | 8.3% | 3.8 | 9.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 330 740 | -1.2% | 5.6% | -0.4 | 1 450 450 116 | 16.2% | 5.4% | 0 | 6.1% |
| DEXALGIN | 1 297 619 | 9.6% | 0.7% | 0 | 545 098 982 | 21.2% | 1.9% | 0.1 | 2.7% |
| ESPUMISAN (ADULTS) | 3 439 361 | -5.6% | 56.7% | -9.9 | 1 744 537 294 | 5.8% | 62.2% | -8.3 | 10.9% |
| ESPUMISAN BABY | 1 070 072 | -10.3% | 38.1% | -3.9 | 664 714 290 | -4.1% | 51.4% | -5.4 | -1.1% |
| FASTUM | 797 893 | -20.1% | 1.2% | -0.3 | 409 730 966 | -10.6% | 2.6% | -0.6 | 1.2% |
| IODOMARIN | 2 171 109 | 5.3% | 19.3% | 0 | 432 985 546 | 11.6% | 8.7% | 0 | 5.4% |
| LIOTON | 1 007 313 | -21.4% | 2.4% | -0.4 | 1 028 521 820 | -1.4% | 4.8% | -0.8 | -6.7% |
| MEZYM | 13 993 869 | 3.0% | 27.8% | 0.2 | 2 141 614 973 | 12.4% | 20.0% | -0.7 | 2.2% |
| MIG 400 | 6 286 981 | -9.4% | 3.4% | -0.5 | 738 755 149 | -5.5% | 2.6% | -0.5 | 2.7% |
| PROSTAMOL | 1 187 338 | -21.3% | 19.7% | -5.5 | 1 665 731 907 | -11.8% | 21.0% | -6.5 | 0.5% |
| RESPERO MYRTOL | 877 042 | 165.4% | 9.0% | 5.4 | 409 537 409 | 159.3% | 8.8% | 4.7 | 6.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 13 176 846 | 20.9% | 6.1% | 0.7 | 2 492 840 586 | 40.5% | 5.7% | 0.9 | 6.5% |
| DEXALGIN | 1 952 122 | 7.4% | 0.7% | 0 | 796 157 267 | 16.9% | 2.0% | 0.1 | 1.6% |
| ESPUMISAN (ADULTS) | 5 077 839 | -0.4% | 59.0% | -7.2 | 2 520 709 494 | 12.1% | 64.4% | -5.8 | 11.8% |
| ESPUMISAN BABY | 1 540 677 | -11.3% | 38.6% | -3 | 943 325 956 | -3.8% | 52.3% | -3.5 | -4.4% |
| FASTUM | 1 184 261 | -18.5% | 1.2% | -0.3 | 591 585 623 | -9.8% | 2.7% | -0.5 | 0.5% |
| IODOMARIN | 3 275 591 | 24.4% | 20.5% | 2.9 | 637 437 162 | 26.1% | 9.3% | 1.1 | 6.8% |
| LIOTON | 1 417 346 | -18.1% | 2.4% | -0.3 | 1 388 547 407 | 0.6% | 5.0% | -0.6 | -6.6% |
| MEZYM | 21 168 760 | 9.9% | 29.2% | 1.5 | 3 144 749 667 | 16.8% | 21.1% | 0.2 | 4.4% |
| MIG 400 | 9 238 664 | -2.2% | 3.5% | -0.1 | 1 073 924 250 | 1.8% | 2.7% | -0.2 | 1.6% |
| PROSTAMOL | 1 817 866 | -14.8% | 20.8% | -3.8 | 2 477 952 691 | -6.5% | 22.2% | -4.8 | 0.9% |
| RESPERO MYRTOL | 1 293 371 | 130.8% | 8.5% | 4.5 | 596 485 558 | 121.1% | 8.3% | 3.8 | 9.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 190 168 | 31.8% | 3.8% | 0.1 | 38 811 488 | 33.7% | 3.8% | 0.1 | 29.1% |
| DEXALGIN | 19 805 | 9.3% | 0.3% | 0 | 9 424 692 | 10.5% | 1.0% | 0 | 9.4% |
| ESPUMISAN (ADULTS) | 67 004 | 2.5% | 47.3% | -0.8 | 35 390 881 | 3.4% | 53.1% | -0.6 | 4.3% |
| ESPUMISAN BABY | 25 912 | 2.8% | 33.1% | -0.3 | 16 886 702 | 2.6% | 46.8% | -0.2 | 3.6% |
| FASTUM | 16 503 | 3.5% | 0.8% | 0 | 9 107 843 | 3.8% | 2.0% | -0.1 | 9.0% |
| IODOMARIN | 69 109 | 3.3% | 23.2% | -0.2 | 12 806 239 | 1.8% | 9.7% | -0.3 | 4.3% |
| LIOTON | 19 368 | 0.3% | 1.8% | -0.2 | 20 853 357 | 0.3% | 3.8% | -0.3 | 9.4% |
| MEZYM | 245 436 | 7.7% | 19.1% | -0.4 | 37 700 689 | 7.5% | 13.8% | -0.1 | 9.9% |
| MIG 400 | 169 028 | 9.1% | 2.8% | 0 | 20 075 625 | 8.9% | 2.2% | 0 | 9.4% |
| PROSTAMOL | 25 669 | 8.4% | 15.2% | -0.2 | 35 414 061 | 8.1% | 16.3% | 0.1 | 9.9% |
| RESPERO MYRTOL | 27 274 | 31.9% | 7.3% | -0.3 | 13 112 470 | 32.4% | 7.6% | -0.3 | 38.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| DEXALGIN | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| ESPUMISAN (ADULTS) | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| ESPUMISAN BABY | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| FASTUM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| IODOMARIN | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| LIOTON | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| MEZYM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| MIG 400 | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| PROSTAMOL | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| RESPERO MYRTOL | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs